关键词：小儿疫苗；儿童；免疫接种；给予保护；防止；传染病
摘 要：Pediatric vaccines are used for the immunization of children to give protection against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the classification adopted by the US FDA, children are classified as newborn, infant, child, and adolescent, ranging from birth to 21 years of age. However, the EMA classifies pediatrics as ranging from birth to 18 years of age.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Route of

Administration

07.1 Oral

07.2 Parenteral

08. Market Segmentation by Product Type

08.1 Polysaccharide Vaccines

08.2 Conjugate Vaccines

09. Geographical Segmentation

09.1 Pediatric Vaccine Market in Americas

09.1.1 Market Size and Forecast

09.1.2 Pediatric Vaccine Market in US

09.1.3 Pediatric Vaccine Market in Latin America

09.2 Pediatric Vaccine Market in EMEA Region

09.2.1 Market Size and Forecast

09.2.2 Pediatric Vaccine Market in Europe

09.3 Pediatric Vaccine Market in APAC Region

09.3.1 Market Size and Forecast

09.3.2 Pediatric Vaccine Market in China

09.3.3 Pediatric Vaccine Market in India

09.3.4 Pediatric Vaccine Market in Japan

10. Key Leading Countries

10.1 US

10.2 China

10.3 India

10.4 Japan

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Mergers and Acquisitions

18.2 Market Share Analysis 2013

18.2.1 GlaxoSmithKline

18.2.2 Sanofi

18.2.3 Pfizer

18.2.4 Merck

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 GlaxoSmithKline

19.1.1 Key Facts

19.1.2 Business Overview

19.1.3 Business Segmentation

19.1.4 Business Segmentation by Revenue 2012 and 2013

19.1.5 Geographical Segmentation by Revenue

19.1.6 Pipeline Products

19.1.7 Business Strategy

19.1.8 Key Information

19.1.9 SWOT Analysis

19.2 Merck

19.2.1 Key Facts

19.2.2 Business Overview

19.2.3 Business Segmentation by Revenue 2013

19.2.4 Business Segmentation by Revenue 2012 and 2013

19.2.5 Geographical Segmentation by Revenue

19.2.6 Business Strategy

19.2.7 Key Developments

19.2.8 SWOT Analysis

19.3 Pfizer

19.3.1 Key Facts

19.3.2 Business Description

19.3.3 Business Segmentation

19.3.4 Business Segmentation by Revenue 2013

19.3.5 Business Segmentation by Revenue 2012 and 2013

19.3.6 Geographical Segmentation by Revenue

19.3.7 Business Strategy

19.3.8 Key Developments

19.3.9 SWOT Analysis

19.4 Sanofi

19.4.1 Key Facts

19.4.2 Business Overview

19.4.3 Business Segmentation by Revenue 2013

19.4.4 Business Segmentation by Revenue 2012 and 2013

19.4.5 Geographical Segmentation by Revenue 2013

19.4.6 Business Strategy

19.4.7 Key Developments

19.4.8 SWOT Analysis

20. Other Reports in this Series